Meeting abstract

ZIPRASIDONE AS A POSSIBLE CAUSE OF CLEFT PALATE IN A NEWBORN

Marija Vučić Peitl ; Psychiatric Clinic of KBC Rijeka, Cambijerijeva 17/7, 51000 Rijeka, Croatia
Daniela Petrić ; Psychiatric Clinic of KBC Rijeka, Cambijerijeva 17/7, 51000 Rijeka, Croatia
Vjekoslav Peitl ; Psychiatric Clinic of KBC Rijeka, Cambijerijeva 17/7, 51000 Rijeka, Croatia

Abstract

Use of antipsychotic medication during the entire course of pregnancy in patients suffering from schizophrenia is frequently
necessary as discontinuation of therapy can lead to relapse of the illness which can be far more severe for the mother, but also for
the fetus. That is the case why third generation antipsychotics, so called atypical antipsychotics, are also being used during the
pregnancy, but their effects are not fully researched. Use of ziprasidone as a third generation antipsychotic, and its effects during the
pregnancy in patients suffering from various mental illnesses is very rarely described in scientific literature. There is even fewer
information regarding eventual adverse events of ziprasidone in newborn babies of mothers that have been treated with ziprasidone
during the entire course of pregnancy.
This paper will be based around a case report of a female patient suffering from schizophrenia who has been treated with
ziprasidone during the entire course of her pregnancy and whose newborn baby was diagnosed with a cleft palate (palatoschisis) at
the time of birth.

Keywords

ziprasidone; newborn; cleft palate

Hrčak ID:

48647

URI

https://hrcak.srce.hr/48647

Publication date:

10.2.2010.

Visits: 1.307 *